Antithrombotic strategies after transcatheter aortic valve replacement a network meta-analysis
The optimal antithrombotic regimen for patients without an indication for oral anticoagulation (OAC) after transcatheter aortic valve replacement (TAVR) remains unclear. We conducted a network meta-analysis of randomized controlled trials to clarify the best postoperative antithrombotic regimen. We...
Saved in:
| Main Authors: | Mengxiao Shi, Ying Wu, Qing Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1496334/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Utilization and Outcomes of Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement (TAVR)
by: Agam Bansal, et al.
Published: (2025-05-01) -
Perioperative Management of Patients Receiving Antithrombotic Therapy in Schemes and Algorithms
by: O. N. Dzhioeva, et al.
Published: (2023-01-01) -
PATIENTS WITH ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOSPITALIZATION STRUCTURE AND ANTITHROMBOTIC THERAPY (RECVASA AF-KURSK REGISTRY)
by: V. P. Mikhin, et al.
Published: (2017-05-01) -
Novel transcatheter aortic valve replacement devicesCentral MessagePerspective
by: Ankur Sethi, MBBS, FACC, et al.
Published: (2025-03-01) -
Antithrombotic therapy in patients with atrial fibrillation hospitalised with myocardial infarction in 2016-2023: timeliness of clinical guideline adherence
by: K. G. Pereverzeva, et al.
Published: (2025-08-01)